Claire Dooley

We're watching corporatism.

So I know we mentioned before when I came on, there was George Yankopoulos of Regeneron, DJ Sayo of Neuralink.

So you had folks like that in the room, Cole Carney of CRISPR.

And so the article is really my experience of going to the Maha Summit and from start to finish, what's going through my mind as someone who has this background and has experienced

I think this is a chance for Maha to seize that kind of power in a way that we can be responsible, right?

The pharmaceutical industry has failed us, but we have big tech, biotech coming up, and this is the moment.

So we were just talking about an article I wrote called Inside the Maha Summit, an ex-vaxxers take.

And we've been talking about the big tech takeover type themes when it comes to the Maha space.

I kind of wanted to share a little bit too about some of the details in my article.

And Steve, you know at a summit, the most important thing that doesn't actually happen on stage, it happens in the conversations in the room, correct?

Absolutely.

They're in the room.

And this is something that I feel very empowered by.

I mean, I talked with Lee Rosebush.

He basically has all these compounding pharmacies.

He's working on moving compounding into the US and moving it from China and India.

So I actually mentioned to him, hey, you know, look, there's a bunch of vaccine injured folks.

I mean, what are you doing about that?

And he had a lot of

meaningful comments to say about it.